FDA Inspection 1116497 — Hammersmith Medicines Research
The FDA completed an inspection of Hammersmith Medicines Research on November 22, 2019 in London. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 22, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- London (United Kingdom)
Additional Details
Clinical BA/BE